Rev-ErbA agonist marketed as 'exercise in a bottle'.
Typical dose range: 20–40 mg
Frequency: Multiple times daily
Route: Oral
Half-life: ~4 hours
Evidence level: Pre-clinical (rodent)
Poor oral bioavailability in humans means real-world results rarely match the rodent data. Not technically a SARM.